2-[(Dihydroisoquinolinyl or dihydroisoindol-2-yl)alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
US3947452A · kind A · utility
12Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 1975 |
| Grant date | Mar 30, 1976 |
| Priority date | — |
| Expiry date | Jan 6, 1995 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D221/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the following formula and their acid addition salts ##SPC1## Wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, nitro, cyano, amino and trifluoromethyl; A is a straight or branched chain alkylene of 1 to 8 carbons; and m is 1 or 2 are disclosed. These compounds exhibit antidepressant and anti-anxiety activity. In addition these compounds are useful as antiinflammatory agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.